Sanjoy K. Dutta

General Surgery
South San Francisco, CA 94080

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

Journal: Diabetes care
Published: May 04, 2026

Screening and Monitoring for Presymptomatic Type 1 Diabetes: A Time for Action.

Screening and Monitoring for Presymptomatic Type 1 Diabetes: A Time for Action.

Journal: Hormone research in paediatrics
Published: January 16, 2026

Screening and monitoring for presymptomatic type 1 diabetes: a time for action.

Screening and monitoring for presymptomatic type 1 diabetes: a time for action.

Journal: Hormone research in paediatrics
Published: January 16, 2026

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.

Journal: The lancet. Diabetes & endocrinology
Published: August 08, 2025

The Urgent Need for Breakthrough Therapies and a World Without Type 1 Diabetes.

The Urgent Need for Breakthrough Therapies and a World Without Type 1 Diabetes.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 12, 2025

Future Directions and Clinical Trial Considerations for Novel Islet β-Cell Replacement Therapies for Type 1 Diabetes.

Future Directions and Clinical Trial Considerations for Novel Islet β-Cell Replacement Therapies for Type 1 Diabetes.

Journal: Diabetes
Published: December 20, 2024

Erratum. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care 2024;47:1276-1298.

Erratum. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care 2024;47:1276-1298.

Journal: Diabetes care
Published: September 06, 2024

Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes.

Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes.

Journal: Diabetologia
Published: September 04, 2024

Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].

Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].

Journal: Diabetologia
Published: August 08, 2024

TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial.

TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial.

Journal: Frontiers in immunology
Published: July 25, 2024

Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.

Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.

Journal: Diabetologia
Published: June 23, 2024

Cohort profile: the 'Biomarkers of heterogeneity in type 1 diabetes' study-a national prospective cohort study of clinical and metabolic phenotyping of individuals with long-standing type 1 diabetes in the Netherlands.

Cohort profile: the 'Biomarkers of heterogeneity in type 1 diabetes' study-a national prospective cohort study of clinical and metabolic phenotyping of individuals with long-standing type 1 diabetes in the Netherlands.

Journal: BMJ open
Published: June 21, 2024
Showing 1-12 of 32

Last Updated: 09/26/2026